Apoptosis-related genes expressed in cardiovascular development and disease: An EST approach

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 621-629

  Rezvani, Mojgan ^a   Barrans, J David ^a   Dai, Ken Shwo ^a   Liew, Choong Chin ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Apoptosis; Developmental biology; Gene expression; Sequence (DNA RNA prot)

Indexed keywords

AMINO ACID; CASPASE; DNA; PROTEIN P53; RNA; TUMOR NECROSIS FACTOR; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DNA SEQUENCE; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RNA SEQUENCE; UNINDEXED SEQUENCE;

ANIMALS; APOPTOSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CASPASE 1; EXPRESSED SEQUENCE TAGS; FAS LIGAND PROTEIN; GENE EXPRESSION; GENES, APC; GENES, BCL-2; GENES, P53; HUMANS; MEMBRANE GLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA; ZINC FINGERS;

EID: 0033984621     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00383-1     Document Type: Review

References (82)

1. Jacobson M.D., Weil M., Raff M.C. Programmed cell death in animal development. Cell. 88:1997;347-354.
2. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
3. Cheng W. Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. J Clin Invest. 96:1995;2247-2259.
4. Colucci W.S. Apoptosis in the heart. N Engl J Med. 335:1996;1224-1226.
5. Narula J., Haider N., Virmani R., et al. Programmed myocyte death in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
6. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
7. Reutelingsperger C. Molecular biology of apoptosis. Impact of apoptosis (programmed cell death) for clinical laboratory sciences. 50th Annual AACC Meeting, Chicago, 1998. (http://web.apoptosis.net/apoptosis/molbio/index.html).
8. Chester N., Kuo F., Kozak C., O'Hara C.D., Leder P. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev. 12:(21):1998;3382-3393.
9. Laytragoon-Lewin N. Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands. Med Oncol. 15:(1):1998;15-19.
10. Miura M., Zhu H., Rotello R., Hartwieg E.A., Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:(4):1993;653-660.
11. Xue D., Horvitz H.R. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature. 377:(6546):1995;248-251.
12. Hengartner M.O., Horvitz H.R. Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev. 4:(4):1994;581-586.
13. Horvitz H.R. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res. 59:(7 Suppl):1999;1701S-1706S.
14. Kusenda J. Bcl-2 family proteins and leukemia. Neoplasma. 45:(3):1998;117-122.
15. Bruckheimer E.M., Cho S.H., Sarkiss M., Herrmann J., McDonnell T.J. The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol. 62:1998;75-105.
16. Hwang D.M., Dempsey A.A., Wang R.X., et al. A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation. 96:1997;4146-4203.
17. Yuan J.Y., Horvitz H.R. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev Biol. 138:(1):1990;33-41.
18. Yuan J., Horvitz H.R. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development. 116:(2):1992;309-320.
19. Davis D., Wells S. Caspase 3-like activity appears in buffer containing live intact cells. BioRadiations. 103:1999;42-43.
20. Fraser A., McCarthy N., Evan G.I. Biochemistry of cell death. Curr Opin Neurobiol. 6:(1):1996;71-80.
21. Li H., Bergeron L., Cryns V., et al. Activation of caspase-2 in apoptosis. J Biol Chem. 272:(34):1997;21010-21017.
22. Loppnow H., Werdan K., Reuter G., Flad H.D. The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system. Eur Cytokine Netw. 9:(4):1998;675-680.
23. Horiuchi M., Yamada H., Akishita M., Ito M., Tamura K., Dzau V.J. Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells. Hypertension. 33:(1):1999;162-166.
24. Yue T.L., Wang C., Romanic A.M., et al. Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase3. J Mol Cell Cardiol. 30:(3):1998;495-507.
25. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:(5):1994;739-750.
26. Hockenberry D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
27. Hengartner M.O., Horvitz H.R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 76:(4):1994;665-676.
28. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 3:(6):1997;614-620.
29. MacLellan W.R., Schneider M.D. Death by design: Programmed cell death in cardiovascular biology and disease. Circ Res. 81:1997;137-144.
30. Saikumar P., Dong Z., Weinberg J.M., Venkatachalam M.A. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene. 17:(25):1998;3341-3349.
31. Park J.R., Hockenberry D.M. BCL-2, a novel regulator of apoptosis. J Cell Biochem. 60:(1):1996;12-17.
32. von Harsdorf R., Li P.F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 99:(22):1999;2934-21941.
33. Maulik N., Goswami S., Galang N., Das D.K. Differential regulation of Bcl-2, AP-1 and NF-kappaB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett. 443:(3):1999;331-336.
34. Ing D.J., Zang J., Dzau V.J., Webster K.A., Bishopric N.H. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res. 84:(1):1999;21-33.
35. Wang K., Yin X.M., Chao D.T., Milliman C.L., Korsmeyer S.J. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:(22):1996;2859-2869.
36. Wang K., Yin X.M., Copeland N.G., et al. BID, a proapoptotic BCL-2 family member, is localized to mouse chromosome 6 and human chromosome 22q11. Genomics. 53:(2):1998;235-238.
37. Shibahara K., Asano M., Ishida Y., Aoki T., Koike T., Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene. 166:(2):1995;297-301.
38. Boyd J.M., Malstrom S., Subramanian T., et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell. 79:(2):1994;341-351.
39. Chen G., Ray R., Dubik D., et al. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J Exp Med. 186:(12):1997;1975-1983.
40. Chen G., Cizeau J., Vande Velde C., et al. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J Biol Chem. 274:(1):1999;7-10.
41. Toggas S.M., Krady J.K., Billingsley M.L. Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells. Mol Pharmacol. 42:(1):1992;44-56.
42. Dejneka N.S., Patanow C.M., Polavarapu R., Toggas S.M., Krady J.K., Billingsley M.L. Localization and characterization of stannin: relationship to cellular sensitivity to organotin compounds. Neurochem Int. 31:(6):1997;801-815.
43. Nakashima T., Sekiguchi T., Kuraoka A., et al. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells. Mol Cell Biol. 13:(10):1993;6367-6374.
44. Roy N., Mahadevan M.S., McLean M., et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:(1):1995;167-178.
45. Gruss H.J. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res. 26:(3):1996;143-159.
46. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem. 271:(22):1996;12687-1268790.
47. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 - and TNF receptor-induced cell death. Cell. 85:(6):1996;803-815.
48. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:(4):1995;505-512.
49. Chinnaiyan A.M., Tepper C.G., Seldin M.F., et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem. 271:(9):1996;4961-4965.
50. Muzio M., Chinnaiyan A.M., Kischkel F.C., et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:(6):1996;817-827.
51. Fernandes-Alnemri T., Armstrong R.C., Krebs J., et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA. 93:(15):1996;7464-7469.
52. Yamamura T., Nakamura H., Yamamoto T., et al. Fas expression and apoptosis correlate with cardiac dysfunction in patients with dilated cardiomyopathy. Jpn Circ J. 63:(3):1999;149-154.
53. Ishiyama S., Hiroe M., Nishikawa T., et al. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J Immunol. 161:(9):1998;4695-4701.
54. Colston J.T., Chandrasekar B., Freeman G.L. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res. 38:(1):1998;158-168.
55. Toyozaki T., Hiroe M., Tanaka M., Nagata S., Ohwada H., Marumo F. Levels of soluble Fas ligand in myocarditis. Am J Cardiol. 82:(2):1998;246-248.
56. Chu K., Niu X., Williams L.T. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci USA. 92:(25):1995;11894-11898.
57. Park C.G., Lee S.Y., Kandala G., Lee S.Y., Choi Y. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity. 4:(6):1996;583-591.
58. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:(7):1995;1243-1252.
59. Aggarwal S., Gollapudi S., Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol. 162:(4):1999;2154-2161.
60. Wang Y., Huang S., Sah V.P., et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 273:(4):1998;2161-2168.
61. Mackay K., Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem. 274:(10):1999;6272-6279.
62. Ma X.L., Kumar S., Gao F., et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 99:(13):1999;1685-1691.
63. Radomski N., Jost E. Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp Cell Res. 220:(2):1995;434-445.
64. Weiss M.J., Orkin S.H. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci USA. 92:(21):1995;9623-9627.
65. Israeli D., Tessler E., Haupt Y., et al. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J. 16:(14):1997;4384-4392.
66. McClure R.F., Hepperlmann C.J., Paya C.V. Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1. J Biol Chem. 274:(12):1999;7756-7762.
67. Katoh O., Oguri T., Takahashi T., Takai S., Fujiwara Y., Watanabe H. ZK1, a novel Kruppel-type zinc finger gene, is induced following exposure to ionizing radiation and enhances apoptotic cell death on hematopoietic cells. Biochem Biophys Res Comm. 249:(3):1998;595-600.
68. Gabig T.G., Mantel P.L., Rosli R., Crean C.D. Requiem: a novel zinc finger gene essential for apoptosis in myeloid cells. J Biol Chem. 269:(47):1994;29515-29519.
69. English M.A., Licht J.D. Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control. J Biol Chem. 274:(19):1999;13258-13263.
70. Dai K.-S., Liew C.C. Chromosomal, in silico and in vitro expression analysis of cardiovascular-based genes encoding zinc finger proteins. J Mol Cell Cardiol (in press).
71. Clarke A.R., Purdie C.A., Harrison D.J., et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;786-787.
72. Dulic V., Kaufmann W.K., Wilson S.J., et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.
73. Kirshenbaum L.A., de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 96:(5):1997;1580-1585.
74. Pierzchalski P., Reiss K., Cheng W., et al. p53 Induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res. 234:(1):1997;57-65.
75. Kirshenbaum L.A. Regulators of apoptosis in the heart: a matter of life and death. Can J Cardiol. 14:(3):1998;457-460.
76. el-Deiry W.S., Tokino T., Velculescu V.E., et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:(4):1993;817-825.
77. Santoro I.M., Groden J. Alternative splicing of the APC gene and its association with terminal differentiation. Cancer Res. 57:1997;488-494.
78. Rezvani M., Liew CC. Identification of APC gene in human heart and its involvement in myocardial development and disease. 1998;Genome Mapping, Sequencing and Biology, Cold Spring Harbor, New York. (Abstract).
79. Lotem J., Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood. 82:(4):1993;1092-1096.
80. He T.C., Sparks A.B., Rago C., et al. Identification of c-MYC as a target of the APC pathway. Science. 281:(5382):1998;1509-1512.
81. Dempsey A.A., Liew C.C. Genes involved in normal cardiac development. Sheridan D.J. Left ventricular hypertrophy. 1998;61-70 Churchill Livingstone, London.
82. Tan K.T., Dempsey A.A., Liew C.C. Cardiac genes and gene databases for cardiovascular disease genetics. Curr Hypertension Rep. 1:1999;51-58.